KLSE:CAREPLS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Careplus Group Berhad

Market Cap

RM960.6m

Last Updated

2021/07/30 17:50 UTC

Data Sources

Company Financials

Executive Summary

Careplus Group Berhad, an investment holding company, engages in the manufacture, processing, and trade of gloves in South America, North America, Europe, the Middle East, South Africa, Japan, China, Malaysia, India, and Australia. More Details


Snowflake Analysis

Flawless balance sheet and fair value.

Share Price & News

How has Careplus Group Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CAREPLS is more volatile than 75% of MY stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: CAREPLS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of MY stocks.


Market Performance


7 Day Return

-20.2%

CAREPLS

-6.5%

MY Medical Equipment

-1.0%

MY Market


1 Year Return

-52.3%

CAREPLS

-60.3%

MY Medical Equipment

-0.7%

MY Market

Return vs Industry: CAREPLS exceeded the MY Medical Equipment industry which returned -60.3% over the past year.

Return vs Market: CAREPLS underperformed the MY Market which returned -0.7% over the past year.


Shareholder returns

CAREPLSIndustryMarket
7 Day-20.2%-6.5%-1.0%
30 Day4.8%-3.6%-0.4%
90 Day-40.2%-31.9%-5.9%
1 Year-51.3%-52.3%-57.5%-60.3%3.0%-0.7%
3 Year674.9%656.5%88.7%72.7%-2.8%-12.0%
5 Year424.2%411.8%341.7%288.8%9.8%-8.7%

Long-Term Price Volatility Vs. Market

How volatile is Careplus Group Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Careplus Group Berhad undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CAREPLS (MYR1.74) is trading below our estimate of fair value (MYR67.65)

Significantly Below Fair Value: CAREPLS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CAREPLS's PE Ratio (3.8x) is in line with the MY Medical Equipment industry average.

PE vs Market: CAREPLS is good value based on its PE Ratio (3.8x) compared to the MY market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CAREPLS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CAREPLS's PB Ratio (2.6x) is in line with the MY Medical Equipment industry average.


Future Growth

How is Careplus Group Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Careplus Group Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Careplus Group Berhad performed over the past 5 years?

88.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CAREPLS has a high level of non-cash earnings.

Growing Profit Margin: CAREPLS became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: CAREPLS's earnings have grown significantly by 88.2% per year over the past 5 years.

Accelerating Growth: CAREPLS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CAREPLS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.4%).


Return on Equity

High ROE: CAREPLS's Return on Equity (65.3%) is considered outstanding.


Financial Health

How is Careplus Group Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: CAREPLS's short term assets (MYR337.4M) exceed its short term liabilities (MYR217.9M).

Long Term Liabilities: CAREPLS's short term assets (MYR337.4M) exceed its long term liabilities (MYR21.5M).


Debt to Equity History and Analysis

Debt Level: CAREPLS's debt to equity ratio (5.6%) is considered satisfactory.

Reducing Debt: CAREPLS's debt to equity ratio has reduced from 74.4% to 5.6% over the past 5 years.

Debt Coverage: CAREPLS's debt is well covered by operating cash flow (1208.3%).

Interest Coverage: CAREPLS's interest payments on its debt are well covered by EBIT (102.7x coverage).


Balance Sheet


Dividend

What is Careplus Group Berhad current dividend yield, its reliability and sustainability?

2.30%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CAREPLS's dividend (2.3%) is higher than the bottom 25% of dividend payers in the MY market (1.49%).

High Dividend: CAREPLS's dividend (2.3%) is low compared to the top 25% of dividend payers in the MY market (4.17%).


Stability and Growth of Payments

Stable Dividend: CAREPLS has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: CAREPLS's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (4.4%), CAREPLS's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.0yrs

Average management tenure


CEO

Kwee Lim (58 yo)

no data

Tenure

RM840,061

Compensation

Mr. Kwee Shyan Lim serves as the Chief Executive Officer at Careplus Group Berhad and has been its Executive Director since March 30, 2010. Mr. Lim joined PPG in 1988 as a Production Executive and was subs...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Kwee's total compensation is reasonable compared to companies of similar size in the MY market.

Compensation vs Earnings: Kwee's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CAREPLS's management team is seasoned and experienced (11 years average tenure).


Board Members

Experienced Board: CAREPLS's board of directors are considered experienced (9.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.


Top Shareholders

Company Information

Careplus Group Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Careplus Group Berhad
  • Ticker: CAREPLS
  • Exchange: KLSE
  • Founded: 1988
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: RM960.615m
  • Shares outstanding: 552.08m
  • Website: https://www.careplus.com

Number of Employees


Location

  • Careplus Group Berhad
  • Jalan Senawang 3
  • Lot 120 & 121
  • Seremban
  • Negeri Sembilan
  • 70450
  • Malaysia

Listings


Biography

Careplus Group Berhad, an investment holding company, engages in the manufacture, processing, and trade of gloves in South America, North America, Europe, the Middle East, South Africa, Japan, China, Malay...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/30 17:50
End of Day Share Price2021/07/30 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.